Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development
Identifieur interne : 000089 ( Main/Merge ); précédent : 000088; suivant : 000090Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development
Auteurs : Jiantao Zhang [États-Unis] ; Yanmei Hu [États-Unis] ; Rami Musharrafieh [États-Unis] ; Hang Yin [États-Unis] ; Jun Wang [États-Unis]Source :
- Current medicinal chemistry [ 0929-8673 ] ; 2019.
Abstract
Influenza viruses are severe human pathogens that pose persistent threat to public health. Each year more people die of influenza virus infection than that of breast cancer. Due to the limited efficacy associated with current influenza vaccines, as well as emerging drug resistance from small molecule antiviral drugs, there is a clear need to develop new antivirals with novel mechanisms of action. The influenza virus polymerase complex has become a promising target for the development of the next-generation of antivirals for several reasons. Firstly, the influenza virus polymerase, which forms a heterotrimeric complex that consists of PA, PB1, and PB2 subunits, is highly conserved. Secondly, both individual polymerase subunit (PA, PB1, and PB2) and inter-subunit interactions (PA-PB1, PB1-PB2) represent promising drug targets. Lastly, growing insight into the structure and function of the polymerase complex has spearheaded the structure-guided design of new polymerase inhibitors. In this review, we highlight recent progress in drug discovery and assay development targeting the influenza virus polymerase complex and discuss their therapeutic potentials.
Url:
DOI: 10.2174/0929867325666180706112940
PubMed: 29984646
PubMed Central: 6426683
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000882
- to stream Pmc, to step Curation: 000882
- to stream Pmc, to step Checkpoint: 000068
- to stream Ncbi, to step Merge: 000E94
- to stream Ncbi, to step Curation: 000E94
- to stream Ncbi, to step Checkpoint: 000E94
Links to Exploration step
PMC:6426683Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development</title>
<author><name sortKey="Zhang, Jiantao" sort="Zhang, Jiantao" uniqKey="Zhang J" first="Jiantao" last="Zhang">Jiantao Zhang</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hu, Yanmei" sort="Hu, Yanmei" uniqKey="Hu Y" first="Yanmei" last="Hu">Yanmei Hu</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Musharrafieh, Rami" sort="Musharrafieh, Rami" uniqKey="Musharrafieh R" first="Rami" last="Musharrafieh">Rami Musharrafieh</name>
<affiliation wicri:level="1"><nlm:aff id="A2">Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yin, Hang" sort="Yin, Hang" uniqKey="Yin H" first="Hang" last="Yin">Hang Yin</name>
<affiliation wicri:level="1"><nlm:aff id="A3">Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309</wicri:regionArea>
<wicri:noRegion>Colorado 80309</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Jun" sort="Wang, Jun" uniqKey="Wang J" first="Jun" last="Wang">Jun Wang</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A4">BIO5 Institute, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BIO5 Institute, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">29984646</idno>
<idno type="pmc">6426683</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426683</idno>
<idno type="RBID">PMC:6426683</idno>
<idno type="doi">10.2174/0929867325666180706112940</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000882</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000882</idno>
<idno type="wicri:Area/Pmc/Curation">000882</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000882</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000068</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000068</idno>
<idno type="wicri:Area/Ncbi/Merge">000E94</idno>
<idno type="wicri:Area/Ncbi/Curation">000E94</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E94</idno>
<idno type="wicri:doubleKey">0929-8673:2019:Zhang J:focusing:on:the</idno>
<idno type="wicri:Area/Main/Merge">000089</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development</title>
<author><name sortKey="Zhang, Jiantao" sort="Zhang, Jiantao" uniqKey="Zhang J" first="Jiantao" last="Zhang">Jiantao Zhang</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hu, Yanmei" sort="Hu, Yanmei" uniqKey="Hu Y" first="Yanmei" last="Hu">Yanmei Hu</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Musharrafieh, Rami" sort="Musharrafieh, Rami" uniqKey="Musharrafieh R" first="Rami" last="Musharrafieh">Rami Musharrafieh</name>
<affiliation wicri:level="1"><nlm:aff id="A2">Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yin, Hang" sort="Yin, Hang" uniqKey="Yin H" first="Hang" last="Yin">Hang Yin</name>
<affiliation wicri:level="1"><nlm:aff id="A3">Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309</wicri:regionArea>
<wicri:noRegion>Colorado 80309</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Jun" sort="Wang, Jun" uniqKey="Wang J" first="Jun" last="Wang">Jun Wang</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A4">BIO5 Institute, The University of Arizona, Tucson, Arizona 85721, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>BIO5 Institute, The University of Arizona, Tucson, Arizona 85721</wicri:regionArea>
<wicri:noRegion>Arizona 85721</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Current medicinal chemistry</title>
<idno type="ISSN">0929-8673</idno>
<idno type="eISSN">1875-533X</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Influenza viruses are severe human pathogens that pose persistent threat to public health. Each year more people die of influenza virus infection than that of breast cancer. Due to the limited efficacy associated with current influenza vaccines, as well as emerging drug resistance from small molecule antiviral drugs, there is a clear need to develop new antivirals with novel mechanisms of action. The influenza virus polymerase complex has become a promising target for the development of the next-generation of antivirals for several reasons. Firstly, the influenza virus polymerase, which forms a heterotrimeric complex that consists of PA, PB1, and PB2 subunits, is highly conserved. Secondly, both individual polymerase subunit (PA, PB1, and PB2) and inter-subunit interactions (PA-PB1, PB1-PB2) represent promising drug targets. Lastly, growing insight into the structure and function of the polymerase complex has spearheaded the structure-guided design of new polymerase inhibitors. In this review, we highlight recent progress in drug discovery and assay development targeting the influenza virus polymerase complex and discuss their therapeutic potentials.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000089 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000089 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Merge |type= RBID |clé= PMC:6426683 |texte= Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:29984646" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
This area was generated with Dilib version V0.6.33. |